FME:ETR
Fresenius Medical Care AG
€ ३८.४४
arrow_downward
-०.१३%(-०.०५०) 1D
सेप्टेम्बर ११, १७:३५:२० GMT+२ · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for FME...
Open
€ ३८.७४
High
€ ३९.१०
Low
€ ३८.४४
Mkt. cap
१०.३२ अरब
Avg. vol.
८.४१ लाख
Volume
०.००
Dividend
३.८८%
Quarterly dividend
€ ०.३७
Ex-dividend date
२०२६ मे २२
P/E ratio
११.५६
52-wk high
€ ४७.८६
52-wk low
€ ३४.५७
EPS
€ ३.३३
Shares outstanding
२६.८६ करोड
No. of employees
१ लाख
Open
€ ३८.७४
High
€ ३९.१०
Low
€ ३८.४४
Mkt. cap
१०.३२ अरब
Avg. vol.
८.४१ लाख
Volume
०.००
Dividend
३.८८%
Quarterly dividend
€ ०.३७
Ex-dividend date
२०२६ मे २२
P/E ratio
११.५६
52-wk high
€ ४७.८६
52-wk low
€ ३४.५७
EPS
€ ३.३३
Shares outstanding
२६.८६ करोड
No. of employees
१ लाख
News stories
From web sources and news partners
ad-hoc-news.de
·
१७ घण्टा पहिले
Fresenius Medical Care stock holds steady as analysts stay cautious
Profile
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease, which requires patients to undergo dialysis 3 times per week for the rest of their lives.
With a global headquarters in Bad Homburg vor der Höhe, Germany, and a North American headquarters in Waltham, Massachusetts, it has a 38% market share of the dialysis market in the United States. It also operates 42 production sites, the largest of which are in the U.S., Germany, and Japan.
The company is 32% owned by Fresenius and, as of 2020, generates around 50% of the group's revenue.
As of 2024, the company was ranked as #612 on the World's Best Employers list published by Forbes. Wikipedia
About Fresenius Medical Care AG